...
首页> 外文期刊>Journal of Ethnopharmacology: An Interdisciplinary Journal Devoted to Bioscientific Research on Indigenous Drugs >Comparison of toxic reaction of Tripterygium wilfordii multiglycoside in normal and adjuvant arthritic rats.
【24h】

Comparison of toxic reaction of Tripterygium wilfordii multiglycoside in normal and adjuvant arthritic rats.

机译:雷公藤多甙对正常和佐剂关节炎大鼠毒性反应的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM OF THE STUDY: Tripterygium wilfordii multiglycoside (GTW), an authorized Chinese patent drug, is used for treatment of rheumatoid arthritis and other immune disease. This study was to determine whether GTW induced different toxic reactions in adjuvant arthritis rats (AA rats) compared to those in normal rats. MATERIALS AND METHODS: To prepare arthritic rat model, male Sprague-Dawley (SD) rats were immunized by injecting complete Freund's Adjuvant into right hind footpad. And then, GTW was given to rats intragastrically at dosage of 7 or 105 mg kg(-1)day(-1) from day 15 to day 28 after immunization. Routine clinical parameters and histopathologic changes of liver, kidney and testis were examined. Metabolic profiling in serum of groups was analyzed by LC-MS. A principal component analysis (PCA) and partial-least-squares discriminate analysis (PLS-DA) were carried out combined with mass spectrometry (MS) data set. All the quantitative data were performed by two-way ANOVA analysis following Student's t-test. RESULTS AND CONCLUSIONS: Treatment with GTW at both doses could diminish the right and left hind paws swelling. There was slight lipoid degeneration in hepatic tissue of normal rats treated by high dose of GTW, but there were not distinctly pathological changes in hepatic tissue of AA rats treated by GTW. Compared normal rats administered with GTW, no statistically significant difference in the serum alanine aminotransferase (ALT), creatinine (CRE), and blood urea nitrogen (BUN) levels were observed. However, the serum aspartate aminotransferase (AST) level was significant decreased in AA rats under exposure GTW compared with normal rats in the same conditions (p<0.05), which indicated that GTW could offer a different liver toxic reaction in normal and AA rats. The metabolic analysis showed that a clear separation of PCA and PLS-DA score spot in normal rats, but not separation was seen in AA rats perturbed with low dosage GTW. The result indicated low dosage GTW might arouse a general toxic in normal rats but not in AA rats. The biomarker analysis showed that the level of lysophosphatidylcholines (LPCs) was down-regulated, but the level of ursodeoxycholic acid (UDCA) and chenodexycholic acid (CDCA) was up-regulated in AA rats compared with normal rats under exposure GTW. According to pathway analysis of metabolic markers, we conceived that LPC, UDCA and CDCA were the critical intermediates of choline and fatty acid metabolism. And the lipid metabolism was a correlative outcome of GTW induced toxicity in the liver in physiological condition animals. Taken together, GTW could induce different toxic reactions between normal and AA rats, and the lipid metabolism might be part of the mechanism for the hepatic lipidosis or the other liver injury.
机译:研究的目的:雷公藤多甙(GTW)是一种获准的中国专利药物,用于治疗类风湿关节炎和其他免疫疾病。这项研究旨在确定与正常大鼠相比,佐剂型关节炎大鼠(AA大鼠)中GTW是否诱发了不同的毒性反应。材料与方法:为了制备关节炎大鼠模型,通过向右后足垫注射完整的弗氏佐剂来免疫雄性Sprague-Dawley(SD)大鼠。然后,从免疫后第15天到第28天,以7或105 mg kg(-1)day(-1)的剂量给大鼠胃内GTW。检查肝,肾和睾丸的常规临床参数和组织病理学变化。用LC-MS分析各组患者血清中的代谢谱。结合质谱(MS)数据集进行了主成分分析(PCA)和偏最小二乘判别分析(PLS-DA)。所有的定量数据均通过学生t检验后的双向方差分析进行。结果与结论:两种剂量的GTW治疗均可减轻左右后爪肿胀。高剂量GTW治疗的正常大鼠肝组织中有少量脂质样变性,而GTW治疗的AA大鼠的肝组织中没有明显的病理变化。与施用GTW的正常大鼠相比,在血清丙氨酸氨基转移酶(ALT),肌酐(CRE)和血尿素氮(BUN)水平上没有统计学上的显着差异。然而,在相同条件下,暴露于GTW的AA大鼠的血清天门冬氨酸转氨酶(AST)水平与正常大鼠相比显着降低(p <0.05),这表明GTW在正常和AA大鼠中可提供不同的肝毒性反应。代谢分析表明,正常大鼠中PCA和PLS-DA得分点明显分离,但在低剂量GTW干扰下的AA大鼠中未见分离。结果表明,低剂量的GTW可能在正常大鼠中引起一般毒性,而在AA大鼠中则没有。生物标志物分析显示,与暴露于GTW的正常大鼠相比,AA大鼠的溶血磷脂酰胆碱(LPCs)水平下调,而熊去氧胆酸(UDCA)和鹅去氧胆酸(CDCA)则上调。根据代谢标记物的途径分析,我们认为LPC,UDCA和CDCA是胆碱和脂肪酸代谢的关键中间体。脂质代谢是GTW诱导的生理状况动物肝脏毒性的相关结果。两者合计,GTW可以诱发正常和AA大鼠之间的不同毒性反应,脂质代谢可能是肝脂质增多或其他肝损伤机制的一部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号